your market intelligence analyst
Search Results
Edit Save
119,458 results
The selections or defaults defined for this collection may have been too restrictive for this search query. You can refine your results for this search.
Shares of Shanghai Fosun Pharmaceutical (Group) surged as much as 10 per cent after it announced that an application for clinical trials of its novel coronavirus vaccine candidate has been accepted by Beijing.The trial application for the Covid-19 mRNA vaccine – BNT162b1 – in collaboration with German partner BioNTech was accepted by the National Medical Products Administration, the company said in a statement to Hong Kong’s bourse late on Monday."
Orissa POST (India) 07/14/2020 04:33
New Delhi: Sony India Tuesday announced expanded its Extra Bass wireless speaker range at a starting price of Rs 8,990. The speakers support ‘Extra Bass’ sound which is achieved on the XB wireless speaker line-up through Sony’s renowned audio technology. The SRS-XB43, SRS-XB33 and SRS-XB23 speakers will be available from July 16. “Backed by Sony’s […]
SwissInfo (Switzerland) 07/14/2020 04:32
The production of protective face masks should be decentralised and made more democratic, according to two Swiss campaigners. They hope their initiative can prevent cases of fraudulent and ruthless practices by the business community. Marie-Claire Graf, one of the sponsors of the Swiss-led project, says it is highly unethical to try and make a lot of money with health products used to fight the spread of Covid-19. “The issue of exorbitant prices and falsified certificates has taken on a political dimension,” says Graf. The 24-year-old Swiss is an expert on sustainability and a member of the youth constituency of the United Nations Framework Convention on Climate Change. Together with other activists, she has been talking to producers, exper.
Economic Times (India) 07/14/2020 04:32
Hyderabad: Biophore India Pharmaceuticals, a city-based firm, has received license from the Drug Controller General of India (DCGI) to manufacture Favipiravir, a drug used in the finished formulation to treat mild to moderate cases of COVID-19.Besides DCGI's nod to produce the active pharmaceutical ingredient in India, it has been cleared for exports as well.It also received approval in Turkey to export the API in collaboration with a local partner and additionally, the company is in talks with several Indian partners to commercialize the product in India and with Bangladesh and Egypt-based companies for its export, Biophore India said."

Financial Services

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Information Technologies

Job Titles

Legal and Regulatory

Political Entities


Strategic Scenarios



  • Actions
    • Bookmark and Share: Allows you to Bookmark the page for easy future retrieval and sharing with colleagues
    • Email: Opens a pop-up window where you can write a message to the recipient of the email
    • Copy URL: Copies the URL of the requested document for pasting in an email or other document
    • Previous Versions: Only shown if essentially the same document has been republished
  • Saved Searches and Alerts
    • Save your search for later viewing & updates by clicking the blue "Save" button to the right of the search box. 

Click here for more info on Search Results.